{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T13:36:08Z","timestamp":1793712968795,"version":"4.6.1"},"reference-count":18,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T00:00:00Z","timestamp":1782691200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Veterinary Journal"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.tvjl.2026.106758","type":"journal-article","created":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T23:38:42Z","timestamp":1782517122000},"page":"106758","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Computer-aided image analysis for PD-L1 assessment in canine urothelial carcinoma"],"prefix":"10.1016","volume":"318","author":[{"given":"L.V.","family":"Muscatello","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Bacci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Brigand\u00ec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Tugnoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Avallone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Valenti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Giuliano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"D\u2019Annunzio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Benazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Sarli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tvjl.2026.106758_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13000-021-01151-x","article-title":"PD\u2212L1 immunostaining: what pathologists need to know","volume":"16","author":"Akhtar","year":"2021","journal-title":"Diagnostic Pathology"},{"key":"10.1016\/j.tvjl.2026.106758_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-017-17204-5","article-title":"QuPath: Open source software for digital pathology image analysis","volume":"7","author":"Bankhead","year":"2017","journal-title":"Scientific Reports"},{"key":"10.1016\/j.tvjl.2026.106758_bib3","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1056\/NEJMoa1613683","article-title":"Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma","volume":"376","author":"Bellmunt","year":"2017","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.tvjl.2026.106758_bib4","first-page":"133","article-title":"Clinical outcomes of dogs with transitional cell carcinoma receiving medical therapy, with and without partial cystectomy","volume":"62","author":"Bradbury","year":"2021","journal-title":"Canadian Veterinary Journal"},{"issue":"2","key":"10.1016\/j.tvjl.2026.106758_bib5","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/his.13946","article-title":"Inter- and intraobserver agreement of programmed death ligand 1 scoring in head and neck squamous cell carcinoma, urothelial carcinoma and breast carcinoma","volume":"76","author":"Downes","year":"2020","journal-title":"Histopathology"},{"key":"10.1016\/j.tvjl.2026.106758_bib6","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.tvjl.2015.01.017","article-title":"Management of transitional cell carcinoma of the urinary bladder in dogs: a review","volume":"205","author":"Fulkerson","year":"2015","journal-title":"Veterinary Journal"},{"key":"10.1016\/j.tvjl.2026.106758_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/cancers16112003","article-title":"Checkpoint inhibitors in dogs: are we there yet?","volume":"16","author":"Giuliano","year":"2024","journal-title":"Cancers"},{"key":"10.1016\/j.tvjl.2026.106758_bib8","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.527385","article-title":"PD-L1 expression in muscle-invasive urinary bladder urothelial carcinoma according to basal\/squamous-like phenotype","volume":"10","author":"Kim","year":"2020","journal-title":"Frontiers in Oncology"},{"key":"10.1016\/j.tvjl.2026.106758_bib9","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2019.01493","article-title":"Naturally-occurring invasive urothelial carcinoma in dogs, a unique model to drive advances in managing muscle invasive bladder cancer in humans","volume":"9","author":"Knapp","year":"2020","journal-title":"Frontiers in Oncology"},{"key":"10.1016\/j.tvjl.2026.106758_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-021-04229-0","article-title":"Lapatinib as first-line treatment for muscle-invasive urothelial carcinoma in dogs","volume":"12","author":"Maeda","year":"2022","journal-title":"Scientific Reports"},{"key":"10.1016\/j.tvjl.2026.106758_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41698-021-00147-6","article-title":"PD-L1 immunohistochemistry for canine cancers and clinical benefit of anti-PD-L1 antibody in dogs with pulmonary metastatic oral malignant melanoma","volume":"5","author":"Maekawa","year":"2021","journal-title":"npj Precision Oncology"},{"key":"10.1016\/j.tvjl.2026.106758_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0157176","article-title":"Immunohistochemical analysis of PD-L1 expression in canine malignant cancers and PD-1 expression on lymphocytes in canine oral melanoma","volume":"11","author":"Maekawa","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.tvjl.2026.106758_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/cancers14246188","article-title":"Development of monoclonal antibodies targeting canine PD-L1 and PD-1 and their clinical relevance in canine apocrine gland anal sac adenocarcinoma","volume":"14","author":"Minoli","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.tvjl.2026.106758_bib14","article-title":"PDL1 immunohistochemistry in canine neoplasms: Validation of commercial antibodies, standardization of evaluation, and scoring systems","author":"Muscatello","year":"2023","journal-title":"Veterinary Pathology"},{"key":"10.1016\/j.tvjl.2026.106758_bib15","doi-asserted-by":"crossref","DOI":"10.1186\/s42047-022-00112-y","article-title":"Computer-assisted tumor grading, validation of PD-L1 scoring, and quantification of CD8-positive immune cell density in urothelial carcinoma, a visual guide for pathologists using QuPath","volume":"5","author":"Rodrigues","year":"2022","journal-title":"Surgical and Experimental Pathology"},{"key":"10.1016\/j.tvjl.2026.106758_bib16","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/ni1443","article-title":"The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection","volume":"8","author":"Sharpe","year":"2007","journal-title":"Nature Immunology"},{"key":"10.1016\/j.tvjl.2026.106758_bib17","first-page":"195","article-title":"Programmed Cell Death Ligand 1 Expression in Canine Cancer","volume":"30","author":"Shosu","year":"2016","journal-title":"Vivo"},{"key":"10.1016\/j.tvjl.2026.106758_bib18","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/s41571-022-00601-9","article-title":"Mechanisms regulating PD-L1 expression in cancers and associated opportunities for novel small-molecule therapeutics","volume":"19","author":"Yamaguchi","year":"2022","journal-title":"Nature Reviews Clinical Oncology"}],"container-title":["The Veterinary Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1090023326002145?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1090023326002145?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T13:10:32Z","timestamp":1793711432000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1090023326002145"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":18,"alternative-id":["S1090023326002145"],"URL":"https:\/\/doi.org\/10.1016\/j.tvjl.2026.106758","relation":{},"ISSN":["1090-0233"],"issn-type":[{"value":"1090-0233","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Computer-aided image analysis for PD-L1 assessment in canine urothelial carcinoma","name":"articletitle","label":"Article Title"},{"value":"The Veterinary Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tvjl.2026.106758","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"106758"}}